Premier Biomedical Inc Revenue Growth Rates (BIEI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Premier Biomedical Inc  (BIEI)
 

BIEI's Revenue Growth by Quarter and Year

Premier Biomedical Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BIEI Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December 0.00
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.01
FY 0.01





BIEI Revenue fourth quarter 2019 Y/Y Growth Comment
Premier Biomedical Inc reported drop in Revenue in the fourth quarter 2019 by -86.94% to $ 0.00 millions, from the same quarter in 2018.
The fall in the fourth quarter 2019 Premier Biomedical Inc's Revenue compares unfavorably to the Company's average Revenue drop of -57.76%.

Looking into fourth quarter 2019 results within Biotechnology & Pharmaceuticals industry 43 other companies have achieved higher Revenue growth. While Premier Biomedical Inc' s Revenue meltdown of -86.94% ranks overall at the positon no. 3925 in the fourth quarter 2019.


BIEI Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter December -86.94 % -50 % - -
3rd Quarter September - -50 % - -
2nd Quarter June - - - -
1st Quarter March 0 % - - -
FY   -71.74 % 0 % - -

Financial Statements
Premier Biomedical Inc's fourth quarter 2019 Revenue $ 0.00 millions BIEI's Income Statement
Premier Biomedical Inc's fourth quarter 2018 Revenue $ 0.01 millions Quarterly BIEI's Income Statement


BIEI Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter December - 0 % 0 % -
3rd Quarter September - 0 % - -
2nd Quarter June - 0 % - -
1st Quarter March 0 % -50 % - -
FY (Year on Year)   -71.74 % 0 % - -


Back to BIEI Growth rate Comparisons >> Back to BIEI Growth rate Comparisons >>


Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #44
Healthcare Sector #514
Overall #3925

Revenue Y/Y Growth Statistics
High Average Low
-52.24 % -57.76 % -64.11 %
(Sep 30 2019)   (Dec 31 2019)
Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #44
Healthcare Sector #514
Overall #3925
Revenue Y/Y Growth Statistics
High Average Low
-52.24 % -57.76 % -64.11 %
(Sep 30 2019)   (Dec 31 2019)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Premier Biomedical Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIEI's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BIEI's IV. Quarter Q/Q Revenue Comment


Premier Biomedical Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Sep 30 2019)		 12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Mar 31 2019)		 12 Months Ending
(Dec 31 2018)
Cumulative Revenue 12 Months Ending $ 0.01 $ 0.02 $ 0.03 $ 0.04 $ 0.04
Y / Y Revenue Growth (TTM) -64.11 % -52.24 % -56.91 % - -
Year on Year Revenue Growth Overall Ranking # 4454 # 3627 # 3131 # 3214 # 0
Seqeuential Revenue Change (TTM) -35.27 % -17.75 % -23.67 % -11.71 % -13.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 3925 # 3798 # 3302 # 2978 # 3739


Cumulative Revenue growth Comment
Premier Biomedical Inc's cumulative 12 months Revenue continue to drop, but on the faster rate at -64.11% year on year, at Dec 31 2019 compare to the -52.24% decrease at Sep 30 2019. If the Premier Biomedical Inc's fiscal year would end at Dec 31 2019, annual Revenue would be $0 millions.

In the Healthcare sector 592 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3627 to 4454.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 44
Healthcare Sector # 593
Overall # 4454

Revenue TTM Y/Y Growth Statistics
High Average Low
-52.24 %
 -57.76 %
-64.11 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 44
Sector # 514
S&P 500 # 3925
Cumulative Revenue growth Comment
Premier Biomedical Inc's cumulative 12 months Revenue continue to drop, but on the faster rate at -64.11% year on year, at Dec 31 2019 compare to the -52.24% decrease at Sep 30 2019. If the Premier Biomedical Inc's fiscal year would end at Dec 31 2019, annual Revenue would be $0 millions.

In the Healthcare sector 592 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3627 to 4454.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 44
Healthcare Sector # 593
Overall # 4454

Revenue TTM Y/Y Growth Statistics
High Average Low
-52.24 %
-57.76 %
-64.11 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 44
Sector # 514
S&P 500 # 3925




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BIEI's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2019
Palisade Bio Inc 0.00%$ 0.000 millions
Navidea Biopharmaceuticals Inc -0.02%$ -0.018 millions
Logicmark Inc-0.23%$ -0.233 millions
Mannkind Corporation-0.24%$ -0.237 millions
Alpha Pro Tech Ltd -0.46%$ -0.456 millions
Amgen Inc -0.53%$ -0.530 millions
American Bio Medica Corporation-0.57%$ -0.566 millions
Wearable Health Solutions, Inc.-0.58%$ -0.582 millions
Societal Cdmo Inc -0.79%$ -0.787 millions
Ufp Technologies Inc -0.86%$ -0.862 millions
Heska Corporation-0.87%$ -0.872 millions
Orasure Technologies Inc-1.15%$ -1.150 millions
Atrion Corporation-1.32%$ -1.317 millions
Titan Pharmaceuticals Inc -1.54%$ -1.537 millions
Elanco Animal Health Incorporated-1.54%$ -1.539 millions
Global Cord Blood Corp-1.55%$ -1.548 millions
Dynatronics Corporation-1.57%$ -1.574 millions
Phibro Animal Health Corporation-1.93%$ -1.930 millions
Magellan Health inc -2.28%$ -2.276 millions
Aquestive Therapeutics Inc -2.41%$ -2.407 millions
Endo International Plc-2.75%$ -2.745 millions
Scorpius Holdings inc -2.87%$ -2.868 millions
Beone Medicines Ltd -3.03%$ -3.031 millions
Intersect Ent Inc -3.14%$ -3.139 millions
Livanova Plc-3.16%$ -3.163 millions
Ironwood Pharmaceuticals inc -3.36%$ -3.360 millions
Accuray Incorporated-3.41%$ -3.413 millions
Arbutus Biopharma Corp-3.58%$ -3.576 millions
Encision Inc -3.71%$ -3.709 millions
Invacare Holdings Corporation-4.77%$ -4.769 millions


About Premier Biomedical Inc Revenue Growth Rates (BIEI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.